Cargando…
The radiosensitizer 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide induces DNA damage in EMT-6 mammary carcinoma cells
BACKGROUND: DCQ (2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide), a synthetic quinoxaline 1,4-dioxide, enhances the cytotoxic effect of ionizing radiation (IR) in vivo and in vitro. We sought to clarify whether increased radiation-induced DNA damage, decreased rate of damage repair, and the...
Autores principales: | Haykal, Joelle, Geara, Fady, Haddadin, Makhluf J, Smith, Colin A, Gali-Muhtasib, Hala |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716350/ https://www.ncbi.nlm.nih.gov/pubmed/19594955 http://dx.doi.org/10.1186/1748-717X-4-25 |
Ejemplares similares
-
Radiosensitization by 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide under oxia and hypoxia in human colon cancer cells
por: Itani, Wafica, et al.
Publicado: (2007) -
Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21
por: El-Khatib, Mona, et al.
Publicado: (2010) -
Novel 2-(5-Imino-5H-isoquinolones[3,4-b]quinoxalin-7-ylmethyl)-benzonitrile
(DIQ3) and Other Related Derivatives Targeting Colon
Cancer Cells: Syntheses and in Vitro Models
por: Monzer, Alissar, et al.
Publicado: (2019) -
The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway
por: Ghattass, Khaled, et al.
Publicado: (2014) -
The Role of the Cyclin Dependent Kinase Inhibitor p21(cip1/waf1) in Targeting Cancer: Molecular Mechanisms and Novel Therapeutics
por: Al Bitar, Samar, et al.
Publicado: (2019)